About VISSUM Instituto Oftalmológico de Alicante
"Grupo Miranza, grupo líder en centros de excelencia en bienestar ocular. Vissum Grupo Miranza Alicante, oftalmología en Alicante especializada en cataratas, cirugía plástica ocular, cirugía refractiva, córnea y superficie ocular, glaucoma, oftalmología general, oftalmología pediátrica, retina-vítreo, uveítis. Equipo de oftalmólogos en Alicante, profesionales con tecnología de vanguardia."
Clinical Trials at VISSUM Instituto Oftalmológico de Alicante
During the past decade, VISSUM Instituto Oftalmológico de Alicante conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "VISSUM Instituto Oftalmológico de Alicante"
#1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at VISSUM Instituto Oftalmológico de Alicante
According to Clinical.Site data, the most researched conditions in "VISSUM Instituto Oftalmológico de Alicante" are
"Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (1 trials), "Neurotrophic Keratitis" (1 trials), "Normal Subjects, Ametropia" (1 trials) and "Viral Conjunctivitis" (1 trials). Many other conditions were trialed in "VISSUM Instituto Oftalmológico de Alicante" in a lesser frequency.
Clinical Trials Intervention Types at VISSUM Instituto Oftalmológico de Alicante
Most popular intervention types in "VISSUM Instituto Oftalmológico de Alicante" are "Drug" (4 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials), "Lampalizumab" (1 trials) and "Sham" (1 trials). Other intervention names were less common.
Clinical Trials Genders at VISSUM Instituto Oftalmológico de Alicante
The vast majority of trials in "VISSUM Instituto Oftalmológico de Alicante" are
6 trials for "All" genders.
Clinical Trials Status at VISSUM Instituto Oftalmológico de Alicante
Currently, there are NaN active trials in "VISSUM Instituto Oftalmológico de Alicante".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in VISSUM Instituto Oftalmológico de Alicante,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in VISSUM Instituto Oftalmológico de Alicante, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".